Cintas Investing Cash Flow increased by 47.6% to -$101.07M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from -$125.37M to -$101.07M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 46.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$48.55M | -$84.32M | -$67.27M | -$164.72M | -$86.32M | -$86.60M | -$84.83M | -$97.19M | -$113.00M | -$169.84M | -$112.36M | -$221.08M | -$100.06M | -$109.48M | -$239.52M | -$125.37M | -$149.27M | -$116.23M | -$192.85M | -$101.07M |
| QoQ Change | — | -73.7% | +20.2% | -144.8% | +47.6% | -0.3% | +2.0% | -14.6% | -16.3% | -50.3% | +33.8% | -96.8% | +54.7% | -9.4% | -118.8% | +47.7% | -19.1% | +22.1% | -65.9% | +47.6% |
| YoY Change | — | — | — | — | -77.8% | -2.7% | -26.1% | +41.0% | -30.9% | -96.1% | -32.5% | -127.5% | +11.5% | +35.5% | -113.2% | +43.3% | -49.2% | -6.2% | +19.5% | +19.4% |